A deneddylase encoded by Epstein-Barr virus promotes viral DNA replication by regulating the activity of cullin-RING ligases

Nature Cell Biology

Volumn 12, Issue 4, 2010, Pages 351-361

  Gastaldello, Stefano ^a   Hildebrand, Sebastian ^a   Faridani, Omid ^a   Callegari, Simone ^a   Palmkvist, Mia ^a   Di Guglielmo, Claudia ^a   Masucci, Maria G ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CULLIN; CULLIN RING LIGASE; DENNEDDYLASE; NEDD8 PROTEIN; PROTEIN BPLF1; REPLICATION LICENSING FACTOR CDT1; UNCLASSIFIED DRUG; VIRUS ENZYME;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL CYCLE S PHASE; DNA REPLICATION; DNA SYNTHESIS INHIBITION; ENZYME ACTIVITY; ENZYME REGULATION; EPSTEIN BARR VIRUS; GENE FUNCTION; GENE OVEREXPRESSION; HYDROLYSIS; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; VIRUS REPLICATION;

CELL CYCLE PROTEINS; CULLIN PROTEINS; DNA REPLICATION; DNA, VIRAL; GENES, REPORTER; HELA CELLS; HERPESVIRUS 4, HUMAN; HUMANS; HYDROLYSIS; PROTEIN STABILITY; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; S PHASE; TIME FACTORS; TRANSFECTION; UBIQUITINS; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRUS REPLICATION;

HUMAN HERPESVIRUS 4;

EID: 77950519653     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb2035     Document Type: Article

References (50)

1. Glickman, M. H. & Ciechanover, A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82, 373-428 (2002). (Pubitemid 34654457)
2. Ciechanover, A., Orian, A. & Schwartz, A. L. The ubiquitin-mediated proteolytic pathway: mode of action and clinical implications. J Cell Biochem Suppl 34, 40-51 (2000). (Pubitemid 30176732)
3. Reyes-Turcu, F. E., Ventii, K. H. & Wilkinson, K. D. Regulation and cellular roles of ubiq-uitin-specific deubiquitinating enzymes. Annu. Rev. Biochem. 78, 363-397 (2009).
4. Kerscher, O., Felberbaum, R. & Hochstrasser, M. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu. Rev. Cell Dev. Biol. 22, 159-180 (2006).
5. Chiba, T. & Tanaka, K. Cullin-based ubiquitin ligase and its control by NEDD8-conjugating system. Curr. Protein Pept. Sci. 5, 177-184 (2004). (Pubitemid 38647470)
6. Tatham, M. H. et al. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nature Cell Biol. 10, 538-546 (2008).
7. Lallemand-Breitenbach, V. et al. Arsenic degrades PML or PML-RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nature Cell Biol. 10, 547-555 (2008). (Pubitemid 351627374)
8. Duda, D. M. et al. Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation. Cell 134, 995-1006 (2008).
9. Pan, Z. Q., Kentsis, A., Dias, D. C., Yamoah, K. & Wu, K. Nedd8 on cullin: building an expressway to protein destruction. Oncogene 23, 1985-1997 (2004). (Pubitemid 38496728)
10. Isaacson, M. K. & Ploegh, H. L. Ubiquitination, ubiquitin-like modifiers, and deubiq-uitination in viral infection. Cell Host Microbe 5, 559-570 (2009).
11. Loureiro, J. & Ploegh, H. L. Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions. Adv. Immunol. 92, 225-305 (2006). (Pubitemid 44834531)
12. Scheffner, M., Huibregtse, J. M., Vierstra, R. D. & Howley, P. M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75, 495-505 (1993). (Pubitemid 23335075)
13. Boutell, C., Canning, M., Orr, A. & Everett, R. D. Reciprocal activities between herpes simplex virus type 1 regulatory protein ICP0, a ubiquitin E3 ligase, and ubiquitin-specific protease USP7. J. Virol. 79, 12342-12354 (2005). (Pubitemid 41346096)
14. Saridakis, V. et al. Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization. Mol. Cell 18, 25-36 (2005). (Pubitemid 40444645)
15. Randow, F. & Lehner, P. J. Viral avoidance and exploitation of the ubiquitin system. Nature Cell Biol. 11, 527-534 (2009).
16. Young, L. S. & Rickinson, A. B. Epstein-Barr virus: 40 years on. Nature Rev. Cancer 4, 757-768 (2004).
17. Bishop, G. A. & Busch, L. K. Molecular mechanisms of B-lymphocyte transformation by Epstein-Barr virus. Microbes Infect. 4, 853-857 (2002). (Pubitemid 35247448)
18. Tsurumi, T., Fujita, M. & Kudoh, A. Latent and lytic Epstein-Barr virus replication strategies. Rev. Med. Virol. 15, 3-15 (2005). (Pubitemid 40070039)
19. Kudoh, A. et al. Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment. J. Biol. Chem. 280, 8156-8163 (2005). (Pubitemid 40349716)
20. Sompallae, R. et al. Epstein-Barr virus encodes three bona fide ubiquitin-specific proteases. J. Virol. 82, 10477-10486 (2008). (Pubitemid 352691175)
21. Kattenhorn, L. M., Korbel, G. A., Kessler, B. M., Spooner, E. & Ploegh, H. L. A deu-biquitinating enzyme encoded by HSV-1 belongs to a family of cysteine proteases that is conserved across the family Herpesviridae. Mol. Cell 19, 547-557 (2005). (Pubitemid 41140011)
22. Mendoza, H. M. et al. NEDP1, a highly conserved cysteine protease that deNEDDylates Cullins. J. Biol. Chem. 278, 25637-25643 (2003).
23. Borodovsky, A. et al. A novel active site-directed probe specific for deubiquitylat-ing enzymes reveals proteasome association of USP14. EMBO J. 20, 5187-5196 (2001). (Pubitemid 32910913)
24. Nishitani, H. et al. Two E3 ubiquitin ligases, SCF-Skp2 and DDB1-Cul4, target human Cdt1 for proteolysis. EMBO J. 25, 1126-1136 (2006). (Pubitemid 43372125)
25. Busino, L. et al. Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage. Nature 426, 87-91 (2003). (Pubitemid 37432546)
26. Kip1 degradation during S/G2 phase progression of adipocyte hyperplasia. J. Cell Physiol. 211, 101-111 (2007).
27. Ohta, T. & Xiong, Y. Phosphorylation-and Skp1-independent in vitro ubiquitination of E2F1 by multiple ROC-cullin ligases. Cancer Res. 61, 1347-1353 (2001). (Pubitemid 34292554)
28. Cook, J. G. Replication licensing and the DNA damage checkpoint. Front. Biosci. 14, 5013-5030 (2009).
29. Wilsker, D. & Bunz, F. Chk1 phosphorylation during mitosis: a new role for a master regulator. Cell Cycle 8, 1161-1163 (2009).
30. Chen, Y. & Poon, R. Y. The multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability. Front. Biosci. 13, 5016-5029 (2008). (Pubitemid 351599655)
31. Hans, F. & Dimitrov, S. Histone H3 phosphorylation and cell division. Oncogene 20, 3021-3027 (2001). (Pubitemid 32553556)
32. Guerreiro-Cacais, A. O., Uzunel, M., Levitskaya, J. & Levitsky, V. Inhibition of heavy chain and β2-microglobulin synthesis as a mechanism of major histocompatibility complex class I downregulation during Epstein-Barr virus replication. J. Virol. 81, 1390-1400 (2007). (Pubitemid 46167860)
33. Daibata, M., Humphreys, R. E., Takada, K. & Sairenji, T. Activation of latent EBV via anti-IgG-triggered, second messenger pathways in the Burkitt's lymphoma cell line Akata. J. Immunol. 144, 4788-4793 (1990). (Pubitemid 20224117)
34. Chrisp, P. & Clissold, S. P. Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Drugs 41, 104-129 (1991). (Pubitemid 21920729)
35. Yuan, J., Cahir-McFarland, E., Zhao, B. & Kieff, E. Virus and cell RNAs expressed during Epstein-Barr virus replication. J. Virol. 80, 2548-2565 (2006). (Pubitemid 43271560)
36. Kim, Y. & Kipreos, E. T. Cdt1 degradation to prevent DNA re-replication: conserved and non-conserved pathways. Cell Div. 2, 18 (2007).
37. Shen, L. N. et al. Structural basis of NEDD8 ubiquitin discrimination by the deNED-Dylating enzyme NEDP1. EMBO J. 24, 1341-1351 (2005).
38. Schlieker, C. et al. Structure of a herpesvirus-encoded cysteine protease reveals a unique class of deubiquitinating enzymes. Mol. Cell 25, 677-687 (2007). (Pubitemid 46341922)
39. Edelmann, M. J. et al. Structural basis and specificity of human otubain 1-mediated deubiquitination. Biochem. J. 418, 379-390 (2009).
40. Soucy, T. A. et al. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 458, 732-736 (2009).
41. Gredmark-Russ, S. et al. A gammaherpesvirus ubiquitin-specific protease is involved in the establishment of murine gammaherpesvirus 68 infection. J. Virol. 83, 10644-10652 (2009).
42. Bottcher, S. et al. Mutagenesis of the active-site cysteine in the ubiquitin-specific protease contained in large tegument protein pUL36 of pseudorabies virus impairs viral replication in vitro and neuroinvasion in vivo. J. Virol. 82, 6009-6016 (2008). (Pubitemid 351822274)
43. Jarosinski, K., Kattenhorn, L., Kaufer, B., Ploegh, H. & Osterrieder, N. A herpesvirus ubiquitin-specific protease is critical for efficient T cell lymphoma formation. Proc. Natl Acad. Sci. USA 104, 20025-20030 (2007).
44. Davy, C. & Doorbar, J. G2/M cell cycle arrest in the life cycle of viruses. Virology 368, 219-226 (2007). (Pubitemid 350016216)
45. Boehmer, P. E. & Lehman, I. R. Herpes simplex virus DNA replication. Annu. Rev. Biochem. 66, 347-384 (1997). (Pubitemid 27274661)
46. Moffat, J. et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124, 1283-1298 (2006).
47. Hassink, G. C. et al. The ER-resident ubiquitin-specific protease 19 participates in the UPR and rescues ERAD substrates. EMBO Rep. 10, 755-761 (2009).
48. Zhao, B., Schlesiger, C., Masucci, M. G. & Lindsten, K. The ubiquitin specific protease 4 (Usp4) is a new player in the Wnt signalling pathway. J. Cell. Mol. Med. 13, 1886-1895 (2009).
49. Duda, D. M. et al. Structure of a SUMO-binding-motif mimic bound to Smt3p-Ubc9p: conservation of a non-covalent ubiquitin-like protein-E2 complex as a platform for selective interactions within a SUMO pathway. J. Mol. Biol. 369, 619-630 (2007).
50. Yao, G. Q., Grill, S., Egan, W. & Cheng, Y. C. Potent inhibition of Epstein-Barr virus by phosphorothioate oligodeoxynucleotides without sequence specification. Antimicrob. Agents Chemother. 37, 1420-1425 (1993). (Pubitemid 23202365)